Category: Longevity & Anti-Aging
-
Weekend warrior exercise is linked to the same lower risk of dying as spreading workouts across the week. What 21 studies say about training on two days.
-
The first randomized trial of exercise and cancer survival: 80.3% of colon cancer patients stayed cancer-free at five years, against 73.9% given booklets.
-
GLP-1 microdosing promises longevity and lower inflammation. No completed trial has tested it, and every dose curve in the real trials runs the other way.
-
The FDA peptides 2026 vote changed no law: no peptide is on the compounding list, FDA’s reviewers proposed keeping them off, and the vote is not binding.
-
A VITAL sub-study found vitamin D slowed telomere loss by 140 base pairs in 4 years. The honest read on vitamin D telomeres, and why the marketing overshoots.
-
A C15:0 supplement rests on one small trial: 30 young adults, 12 weeks, no weight change. Here is what the fatty15 evidence shows and what food gives you.
-
An organ age test scores each organ from one blood draw. What 43,616 adults show about brain aging, early death, and why the number is not yet personal.
-
No dog longevity drug is approved yet. LOY-002 has cleared two of three FDA sections, and the 1,300-dog trial testing whether it works has not reported.
-
The blue zones’ habits hold up, but the head counts do not: US birth certificates cut records of people past 110 by 69 to 82 percent. Here is the evidence.
-
Klotho longevity shots sell for about $25,000 abroad. One low dose helped aged monkeys remember, but no human trial has yet shown a real benefit in people.
Bio-Hacking.Blog 